Vaccines for Pandemic Influenza
Open Access
- 1 January 2006
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 12 (1) , 66-72
- https://doi.org/10.3201/eid1201.051147
Abstract
Recent outbreaks of highly pathogenic avian influenza in Asia and associated human infections have led to a heightened level of awareness and preparation for a possible influenza pandemic. Vaccination is the best option by which spread of a pandemic virus could be prevented and severity of disease reduced. Production of live attenuated and inactivated vaccine seed viruses against avian influenza viruses, which have the potential to cause pandemics, and their testing in preclinical studies and clinical trials will establish the principles and ensure manufacturing experience that will be critical in the event of the emergence of such a virus into the human population. Studies of such vaccines will also add to our understanding of the biology of avian influenza viruses and their behavior in mammalian hosts.Keywords
This publication has 37 references indexed in Scilit:
- Containing Pandemic Influenza at the SourceScience, 2005
- Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming StrategyThe Journal of Infectious Diseases, 2005
- Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality systemVaccine, 2005
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidateVaccine, 2003
- Principles Underlying the Development and Use of Live Attenuated Cold-Adapted Influenza A and B Virus VaccinesViral Immunology, 2002
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- The Economic Impact of Pandemic Influenza in the United States: Priorities for InterventionEmerging Infectious Diseases, 1999
- Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory IllnessScience, 1998
- USE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A REASSORTANT VIRUS VACCINES IN INFANTS, CHILDREN, YOUNG ADULTS, AND ELDERLY ADULTSInfectious Diseases in Clinical Practice, 1993